About Invitro Biotech Limited
Data last updated:
Invitro Biotech Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 18 July 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U29219TG2001PLC037037. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Invitro Biotech Private Limited. It is led by directors including Sujata Malik and Jeniva Malik.
Its last annual general meeting (AGM) was held on 07 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 507 5th Floor Mayuri Hills Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2020, the company reported a revenue of ₹49.05 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹4.76 Lakh (net margin -9.7%) and EBITDA of -₹3.7 Lakh (EBITDA margin -7.5%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
As per MCA filings, the company has satisfied charges of ₹8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website invitbio.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address507 5th Floor Mayuri Hills Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Invitro Biotech Limited
The main business activity of Invitro Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Invitro Biotech Limited FY 2020 filings available
Invitro Biotech Limited reported revenue of ₹49.05 Lakh (down 33% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Invitro Biotech Limited
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 33% fall in the latest year. EBITDA fell 275% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Invitro Biotech Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹49.05 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.76 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Invitro Biotech Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -9.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Invitro Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Invitro Biotech Limited
Invitro Biotech Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seerance Techno (India) Private Limited | ₹49.85 Lakh (FY 2019) | •••• | •••• | 92.0% | •••• | Indore, Madhya Pradesh, India |
| Generex Power Systems Private Limited | ₹49.78 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Bangalore, Karnataka, India |
| Niya Labs Private Limited | ₹49.59 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Delhi, India |
| Sar Surgical Centre Private Limited | ₹49.38 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | Bhayandar East, Maharashtra, India |
| Medichosp Surgicals Private Limited | ₹49.28 Lakh (FY 2024) | •••• | •••• | 50.0% | •••• | Lucknow, Uttar Pradesh, India |
| Invitro Biotech Limited this company | ₹49.05 Lakh (FY 2020) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Enist Instruments and Services Private Limited | ₹49.01 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| Rit Qik Homoeo Pharmaceuticals Private Limited | ₹48.98 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Yadadri Bhongir, Telangana, India |
| Star Endotech Solutions Private Limited | ₹48.87 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | Kolkata, West Bengal, India |
| Pragyaa Pharmacy Private Limited | ₹48.79 Lakh (FY 2023) | •••• | •••• | 474.0% | •••• | Jaipur, Rajasthan, India |
| Stargenics India Private Limited | ₹48.77 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Invitro Biotech by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Invitro Biotech Limited
Invitro Biotech Limited is audited by VENKATA RAMA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VENKATA RAMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Invitro Biotech Limited
Invitro Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujata Malik | Director | 22 Jan 2016 | 10 Years 8 Months | Current |
| Jeniva Malik | Director | 18 Jul 2001 | 25 Years 2 Months | Current |
| Chandra Vijay Malik | Director | 18 Jul 2001 | 25 Years 2 Months | Current |
Ownership and Shareholding of Invitro Biotech Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Invitro Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Nov 2001 | Bank of Baroda | ₹8 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Invitro Biotech Limited
Employment history and EPFO contributions of people linked to Invitro Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Invitro Biotech Limited
Invitro Biotech has one previous CIN (Corporate Identification Number): U29219AP2001PLC037037. The current CIN is U29219TG2001PLC037037, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U29219TG2001PLC037037 | Current |
| U29219AP2001PLC037037 | Previous |
Recent Activity on Invitro Biotech Limited
Invitro Biotech Limited has 6 board changes on record since 2001: 3 appointments and 3 cessations. The latest: Sujata Malik ceased to be Additional Director on 30 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Invitro Biotech Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Invitro Biotech Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Invitro Biotech Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Invitro Biotech Limited
Invitro Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Invitro Biotech Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invitro Biotech Limited
Invitro Biotech is an active public limited company based in Hyderabad, Telangana, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 18 July 2001 (25+ years old) and is registered under CIN U29219TG2001PLC037037.
Invitro Biotech reported revenue of ₹49.05 Lakh for FY 2020 (down 33% YoY).
Invitro Biotech has 3 current directors:
- Sujata Malik - Director
- Jeniva Malik - Director
- Chandra Vijay Malik - Director
Invitro Biotech reported a net loss of ₹4.76 Lakh (net margin -9.7%) and EBITDA of -₹3.7 Lakh (EBITDA margin -7.5%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Invitro Biotech is -10% over three years and -5% over five years. In the latest year (FY 2020) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.
No. Invitro Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Invitro Biotech is U29219TG2001PLC037037. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invitro Biotech was incorporated on 18 July 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Invitro Biotech by revenue are Seerance Techno (India) Private Limited, Generex Power Systems Private Limited, Niya Labs Private Limited, Sar Surgical Centre Private Limited, Medichosp Surgicals Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Sujata Malik ceased to be Additional Director on 30 Sep 2016. Sujata Malik was appointed as Director on 22 Jan 2016. Jonnalagadda Sudha Lakshmi ceased to be Director on 15 Nov 2015. Invitro Biotech has 6 board changes on record in total.
Invitro Biotech can be reached through the website invitbio.com. Its registered office is in Hyderabad, Telangana, India.